HER2-positive metastatic cervical cancer responsive to first and second-line treatment: A case report

Cervical cancer is the fourth most common malignant disease among women, with metastatic disease having a dismal survival rate compared to localized disease when using standard combination chemotherapy. Next-generation sequencing (NGS) of tumors has allowed for targeted treatments of cancers in pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Fortman, Dylan, Issa, Rochell, Stanbery, Laura, Albrethsen, Mary, Nemunaitis, John, Kasunic, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906699/
https://www.ncbi.nlm.nih.gov/pubmed/31867435
http://dx.doi.org/10.1016/j.gore.2019.100520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906699/
https://www.ncbi.nlm.nih.gov/pubmed/31867435
http://dx.doi.org/10.1016/j.gore.2019.100520

Ejemplares similares